Back to Agenda
To Shape the Future of Patient Labeling Across Regions
Session Chair(s)
Rie Matsui, RPH
Senior Director, Regional Labeling Head for APAC, Pfizer R&D Japan G.K., Japan
In this session we will discuss ongoing initiatives in the field of electronic labeling and look ahead to their potential impact on the future of digital health, with a particular focus on patient product information in the US, EU, Japan, and Asia. This session will also discuss how different approaches to electronic labeling may converge across regions, driving a new patient-centric focus to product information.
Learning Objective : Discuss how emerging trends for electronic labeling are impacting risk communication across the US, EU, Japan and Asia; Describe the challenges of provision of patient product information in the future; Discuss approaches to improving health literacy and adherence to patient labeling; Discuss the possibility of convergence of electronic labeling standards to drive patient centricity across regions.
Speaker(s)
PMDA’s Updates for Electronic Labeling Initiative and Patient-Centric Labeling in Japan
Associate Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Electronic Product Information (ePI) in the EU: Key Principles and Beyond
ePI Product Owner, European Medicines Agency, Netherlands
Electronic Labeling in the US / Canada and A Global eLabeling Vision
Retired, Retired, United States
Dynamic Landscape in Asia for Electronic Labeling and Patient Labeling
Senior Director, Regional Labeling Head for APAC, Pfizer R&D Japan G.K., Japan
Have an account?